Clinical study of injection of platelet rich plasma in the treatment of sacroiliac joint dysfunction

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2400089191

Enrollment

Unknown

Registered

2024-09-03

Start date

2024-01-11

Completion date

Unknown

Last updated

2024-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sacroiliac joint dysfunction

Interventions

Group A:internal sacroiliac joint PRP injection

Group B:internal and external sacroiliac joint PRP injection

Eligibility

Sex/Gender

All

Age

20 Years to 65 Years

Inclusion criteria

Inclusion criteria: 20 to 65 years old, male or female, with definite lumbosacral pain which is limited to the sacroiliac joint, no radiating pain in the lower extremities or limited to the proximal knee joint, lumbar MRI showed no lumbar disc herniation or mild herniation.

Exclusion criteria

Exclusion criteria: History of severe trauma or surgery to the spine, hip or pelvis, severe spinal degeneration (scoliosis, spondylolisthesis, spinal stenosis), deformity, tumor, infection; Unable to cooperate with researchers.

Design outcomes

Primary

Measure	Time frame
Low back pain visual analog score ;	—

Secondary

Measure	Time frame
Oswestry Disability Index;36-item Short-Form,SF-36;Japanese orthopaedic Association;	—

Countries

China

Contacts

Public ContactLyu Zhen

China Rehabilitation Research Center

luzhen1980@126.com+86 134 6672 9211

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026